On Saturday, November 23, 2024, Côte d’Ivoire’s Minister of Health, Public Hygiene, and Universal Health Coverage, Pierre Dimba, shared a groundbreaking announcement during a prostate cancer awareness event. Speaking at the Alassane Ouattara National Center for Medical Oncology and Radiotherapy (CNRAO), he confirmed that prostate cancer is treatable in the country. This declaration marked the National Prostate Cancer Awareness Day, organized by the institution.

The event aimed to raise awareness about the dangers of prostate cancer and the importance of early screening.

“In this Blue November, I am here to announce that the tragedy of prostate cancer can be avoided. Prostate cancer can be cured, and it is possible right here in Côte d’Ivoire,” stated Pierre Dimba.

According to scientific data published on December 31, 2023, 72 out of every 100 patients treated for prostate cancer at the CNRAO survive beyond five years, across all stages of the disease. This is a significant improvement from the national data recorded between 2005 and 2015, which showed a 55% five-year survival rate.

For patients diagnosed early through screening, the results are even more promising. The CNRAO reported that 93 out of every 100 patients survive beyond five years, aligning closely with international standards.

Minister Dimba emphasized early detection and proper treatment as essential conditions for eradicating prostate cancer.

The CNRAO has positioned Côte d’Ivoire as a leader in francophone West Africa, being the first to provide Rapid Arc or VMAT radiotherapy technology in the public sector. This cutting-edge method is globally recognized for its effectiveness in treating prostate cancer.

The Blue Walk initiative, a highlight of the awareness campaign, also took place in several districts of Abidjan. This 5-kilometer walk, completed in 45 minutes, was championed by Minister Pierre Dimba as a call to action for public health and cancer awareness.